Christian Mueller
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
Benkert P, Meier S, Schaedelin S, Manouchehrinia A, Yaldizli O, Maceski A, Oechtering J, Achtnichts L, Conen D, Derfuss T, Lalive P, Mueller C, Müller S, Naegelin Y, Oksenberg J, Pot C, Salmen A, Willemse E, Kockum I, Blennow K, Zetterberg H, Gobbi C, Kappos L, Wiendl H, Berger K, Sormani M, Granziera C, Piehl F, Leppert D, Kuhle J. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol 2022; 21:246-257.
Mar 1, 2022Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
Mar 1, 2022Lancet Neurol 2022; 21:246-257
Benkert Pascal, Meier Stephanie, Schaedelin Sabine, Manouchehrinia Ali, Yaldizli Ozgür, Maceski Aleksandra, Oechtering Johanna, Achtnichts Lutz, Conen David, Derfuss Tobias, Lalive Patrice H, Mueller Christian, Müller Stefanie, Naegelin Yvonne, Oksenberg Jorge R, Pot Caroline, Salmen Anke, Willemse Eline, Kockum Ingrid, Blennow Kaj, Zetterberg Henrik, Gobbi Claudio, Kappos Ludwig, Wiendl Heinz, Berger Klaus, Sormani Maria Pia, Granziera Cristina, Piehl Fredrik, Leppert David, Kuhle Jens
Effectiveness, Adherence, and Safety of Evolocumab in a Swiss Multicenter Prospective Observational Study
Nanchen D, Reichert N, Rossi M, Crljenica C, Mueller C, Mach F, Koskinas K, Rickli H, Bilz S, Carballo D, Sudano I. Effectiveness, Adherence, and Safety of Evolocumab in a Swiss Multicenter Prospective Observational Study. Adv Ther 2021; 39:504-517.
Nov 18, 2021Effectiveness, Adherence, and Safety of Evolocumab in a Swiss Multicenter Prospective Observational Study
Nov 18, 2021Adv Ther 2021; 39:504-517
Nanchen David, Reichert Nina, Rossi Mariagrazia, Crljenica Carmela, Mueller Christian, Mach François, Koskinas Konstantinos C, Rickli Hans, Bilz Stefan, Carballo David, Sudano Isabella
Effect of a strategy of comprehensive vasodilation versus usual care on health-related quality of life among patients with acute heart failure
Belkin M, Münzel T, Erne P, Breidthardt T, Rickli H, Kobza R, de Oliveira Junior M, Danier I, Lopez-Ayala P, Kozhuharov N, Flores D, Walter J, Maeder M, Goudev A, Strebel I, Shrestha S, Gualandro D, Wussler D, Mueller C. Effect of a strategy of comprehensive vasodilation versus usual care on health-related quality of life among patients with acute heart failure. ESC Heart Fail 2021; 8:4218-4227.
Aug 6, 2021Effect of a strategy of comprehensive vasodilation versus usual care on health-related quality of life among patients with acute heart failure
Aug 6, 2021ESC Heart Fail 2021; 8:4218-4227
Belkin Maria, Münzel Thomas, Erne Paul, Breidthardt Tobias, Rickli Hans, Kobza Richard, de Oliveira Junior Mucio Tavares, Danier Isabelle, Lopez-Ayala Pedro, Kozhuharov Nikola, Flores Dayana, Walter Joan, Maeder Micha, Goudev Assen, Strebel Ivo, Shrestha Samyut, Gualandro Danielle Menosi, Wussler Desiree, Mueller Christian
Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure: The GALACTIC Randomized Clinical Trial
Kozhuharov N, Michou E, Gujer S, Gori T, Wenzel P, Pfister O, Conen D, Kapos I, Kobza R, Rickli H, Breidthardt T, Münzel T, Erne P, Mueller C, Simon P, Sionis A, Goudev A, Flores D, Maeder M, Walter J, Shrestha S, Gualandro D, de Oliveira Junior M, Sabti Z, Müller B, Noveanu M, Socrates T, Ziller R, Bayés-Genís A, GALACTIC Investigators. Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure: The GALACTIC Randomized Clinical Trial. JAMA 2019; 322:2292-2302.
Jan 17, 2019Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure: The GALACTIC Randomized Clinical Trial
Jan 17, 2019JAMA 2019; 322:2292-2302
Kozhuharov Nikola, Michou Eleni, Gujer Samuel, Gori Tommaso, Wenzel Philip, Pfister Otmar, Conen David, Kapos Ioannis, Kobza Richard, Rickli Hans, Breidthardt Tobias, Münzel Thomas, Erne Paul, Mueller Christian, Simon Patrick, Sionis Alessandro, Goudev Assen, Flores Dayana, Maeder Micha, Walter Joan, Shrestha Samyut, Gualandro Danielle Menosi, de Oliveira Junior Mucio Tavares, Sabti Zaid, Müller Beat, Noveanu Markus, Socrates Thenral, Ziller Ronny, Bayés-Genís Antoni, GALACTIC Investigators
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial
Jeger R, Stephan F, Mueller C, Rickenbacher P, Coslovsky M, Gilgen N, Osswald S, Kaiser C, Scheller B, Linke A, Mahfoud F, Schreiber M, Farah A, Ohlow M, Mangner N, Möbius-Winkler S, Leibundgut G, Weilenmann D, Wöhrle J, Richter S, BASKET-SMALL 2 Investigators. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet 2018; 392:849-856.
Aug 28, 2018Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial
Aug 28, 2018Lancet 2018; 392:849-856
Jeger Raban V, Stephan Frank-Peter, Mueller Christian, Rickenbacher Peter, Coslovsky Michael, Gilgen Nicole, Osswald Stefan, Kaiser Christoph, Scheller Bruno, Linke Axel, Mahfoud Felix, Schreiber Matthias, Farah Ahmed, Ohlow Marc-Alexander, Mangner Norman, Möbius-Winkler Sven, Leibundgut Gregor, Weilenmann Daniel, Wöhrle Jochen, Richter Stefan, BASKET-SMALL 2 Investigators
Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2
Gilgen N, Butter C, Bruch L, Kaiser C, Hoffmann A, Rickenbacher P, Mueller C, Stephan F, Coslovsky M, Jeger R, Krackhardt F, Zweiker R, Farah A, Scheller B, Ohlow M, Mangner N, Weilenmann D, Wöhrle J, Jamshidi P, Leibundgut G, Möbius-Winkler S, BASKET-SMALL 2 Investigators. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2. Clin Cardiol 2018; 41:569-575.
May 10, 2018Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2
May 10, 2018Clin Cardiol 2018; 41:569-575
Gilgen Nicole, Butter Christian, Bruch Leonhard, Kaiser Christoph, Hoffmann Andreas, Rickenbacher Peter, Mueller Christian, Stephan Frank-Peter, Coslovsky Michael, Jeger Raban, Krackhardt Florian, Zweiker Robert, Farah Ahmed, Scheller Bruno, Ohlow Marc-Alexander, Mangner Norman, Weilenmann Daniel, Wöhrle Jochen, Jamshidi Peiman, Leibundgut Gregor, Möbius-Winkler Sven, BASKET-SMALL 2 Investigators
Diagnostic and prognostic value of cystatin C in acute heart failure
Breidthardt T, Nestelberger T, Boeddinghaus J, Badertscher P, Barata S, Shrestha S, Gayat E, Kozhuharov N, Twerenbold R, Rassouli F, Ziller R, Sabti Z, Mueller C. Diagnostic and prognostic value of cystatin C in acute heart failure. Clin Biochem 2017
Jul 26, 2017Diagnostic and prognostic value of cystatin C in acute heart failure
Jul 26, 2017Clin Biochem 2017
Breidthardt Tobias, Nestelberger Thomas, Boeddinghaus Jasper, Badertscher Patrick, Barata Sara, Shrestha Samyut, Gayat Etienne, Kozhuharov Nikola, Twerenbold Raphael, Rassouli Frank, Ziller Ronny, Sabti Zaid, Mueller Christian
Incremental Value of Preoperative Copeptin for Predicting Myocardial Injury
Mauermann E, Bolliger D, Seeberger E, Puelacher C, Corbiere S, Filipovic M, Seeberger M, Mueller C, Lurati Buse G. Incremental Value of Preoperative Copeptin for Predicting Myocardial Injury. Anesth Analg 2016; 123:1363-1371.
Dec 1, 2016Incremental Value of Preoperative Copeptin for Predicting Myocardial Injury
Dec 1, 2016Anesth Analg 2016; 123:1363-1371
Mauermann Eckhard, Bolliger Daniel, Seeberger Esther, Puelacher Christian, Corbiere Sydney, Filipovic Miodrag, Seeberger Manfred, Mueller Christian, Lurati Buse Giovanna
Biomarkers of cardiovascular stress in obstructive sleep apnea
Maeder M, Mueller C, Schoch O, Ammann P, Rickli H. Biomarkers of cardiovascular stress in obstructive sleep apnea. Clin Chim Acta 2016; 460:152-63.
Jul 2, 2016Biomarkers of cardiovascular stress in obstructive sleep apnea
Jul 2, 2016Clin Chim Acta 2016; 460:152-63
Maeder Micha, Mueller Christian, Schoch Otto, Ammann Peter, Rickli Hans
Prediction of mortality using quantification of renal function in acute heart failure
Weidmann Z, Haas L, Jaeger C, Wildi K, Puelacher C, Honegger U, Wagener M, Wittmer S, Schumacher C, Krivoshei L, Hillinger P, Osswald S, Stallone F, Pershyna K, Breidthardt T, Twerenbold R, Züsli C, Nowak A, von Eckardstein A, Erne P, Rentsch K, de Oliveira M, Gualandro D, Maeder M, Rubini Gimenez M, Mueller C. Prediction of mortality using quantification of renal function in acute heart failure. Int J Cardiol 2015; 201:650-7.
Aug 11, 2015Prediction of mortality using quantification of renal function in acute heart failure
Aug 11, 2015Int J Cardiol 2015; 201:650-7
Weidmann Zoraida Moreno, Haas Laurent, Jaeger Cedric, Wildi Karin, Puelacher Christian, Honegger Ursina, Wagener Max, Wittmer Severin, Schumacher Carmela, Krivoshei Lian, Hillinger Petra, Osswald Stefan, Stallone Fabio, Pershyna Kateryna, Breidthardt Tobias, Twerenbold Raphael, Züsli Christina, Nowak Albina, von Eckardstein Arnold, Erne Paul, Rentsch Katharina, de Oliveira Mucio T, Gualandro Danielle, Maeder Micha, Rubini Gimenez Maria, Mueller Christian
Comprehensive biomarker profiling in patients with obstructive sleep apnea
Maeder M, Rickli H, Twerenbold R, Brutsche M, Hilti J, Thalmann G, Wildi K, Estis J, Todd J, Christ M, Strobel W, Mueller C. Comprehensive biomarker profiling in patients with obstructive sleep apnea. Clin Biochem 2014
Sep 16, 2014Comprehensive biomarker profiling in patients with obstructive sleep apnea
Sep 16, 2014Clin Biochem 2014
Maeder Micha, Rickli Hans, Twerenbold Raphael, Brutsche Martin, Hilti Jonas, Thalmann Gregor, Wildi Karin, Estis Joel, Todd John, Christ Michael, Strobel Werner, Mueller Christian
Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide
Zurek M, Maeder M, Brutsche M, Lüthi A, Twerenbold R, Freese M, Rickli H, Mueller C. Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide. Eur J Appl Physiol 2014; 114:815-24.
Jan 5, 2014Midregional pro-adrenomedullin and copeptin: exercise kinetics and association with the cardiopulmonary exercise response in comparison to B-type natriuretic peptide
Jan 5, 2014Eur J Appl Physiol 2014; 114:815-24
Zurek Marzena, Maeder Micha, Brutsche Martin, Lüthi Adrian, Twerenbold Raphael, Freese Michael, Rickli Hans, Mueller Christian
Prevalence, extent, and independent predictors of silent myocardial infarction
Arenja N, Osswald S, Hochgruber T, Sou S, Reichlin T, Roost K, Brinkert M, Ehl N, Mueller C, Zellweger M. Prevalence, extent, and independent predictors of silent myocardial infarction. Am J Med 2013; 126:515-22.
Apr 15, 2013Prevalence, extent, and independent predictors of silent myocardial infarction
Apr 15, 2013Am J Med 2013; 126:515-22
Arenja Nisha, Osswald Stefan, Hochgruber Thomas, Sou Seoung Mann, Reichlin Tobias, Roost Katharina, Brinkert Miriam, Ehl Niklas, Mueller Christian, Zellweger Michael J
Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo?
Zurek M, Maeder M, Brutsche M, Christ A, Bosshard P, Ziller R, Rickli H, Kaye D, Mueller C. Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo?. Int J Cardiol 2012
Nov 22, 2012Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo?
Nov 22, 2012Int J Cardiol 2012
Zurek Marzena, Maeder Micha, Brutsche Martin H, Christ Andreas, Bosshard Piet, Ziller Ronny, Rickli Hans, Kaye David M, Mueller Christian
Biomarkers and peak oxygen uptake in patients with chronic lung disease
Maeder M, Bergmann A, Morgenthaler N, Staub D, Meissner J, Reiter M, Socrates T, Arenja N, Brutsche M, Mueller C. Biomarkers and peak oxygen uptake in patients with chronic lung disease. Respiration 2010; 80:543-52.
Jul 17, 2010Biomarkers and peak oxygen uptake in patients with chronic lung disease
Jul 17, 2010Respiration 2010; 80:543-52
Maeder Micha, Bergmann Andreas, Morgenthaler Nils G, Staub Daniel, Meissner Julia, Reiter Miriam, Socrates Thenral, Arenja Nisha, Brutsche Martin, Mueller Christian
Copeptin response to clinical maximal exercise tests
Maeder M, Struck J, Bergmann A, Morgenthaler N, Meissner J, Reiter M, Socrates T, Arenja N, Brutsche M, Staub D, Mueller C. Copeptin response to clinical maximal exercise tests. Clin Chem 2010; 56:674-6.
Apr 1, 2010Copeptin response to clinical maximal exercise tests
Apr 1, 2010Clin Chem 2010; 56:674-6
Maeder Micha, Struck Joachim, Bergmann Andreas, Morgenthaler Nils G, Meissner Julia, Reiter Miriam, Socrates Thenral, Arenja Nisha, Brutsche Martin, Staub Daniel, Mueller Christian
Midregional pro-A-type natriuretic peptide for the evaluation of exercise intolerance
Maeder M, Bergmann A, Morgenthaler N, Reichlin T, Potocki M, Schaub N, Breidthardt T, Noveanu M, Staub D, Christ A, Brutsche M, Mueller C. Midregional pro-A-type natriuretic peptide for the evaluation of exercise intolerance. International journal of cardiology 2009
Dec 22, 2009Midregional pro-A-type natriuretic peptide for the evaluation of exercise intolerance
Dec 22, 2009International journal of cardiology 2009
Maeder Micha, Bergmann Andreas, Morgenthaler Nils G, Reichlin Tobias, Potocki Mihael, Schaub Nora, Breidthardt Tobias, Noveanu Markus, Staub Daniel, Christ Andreas, Brutsche Martin, Mueller Christian
Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides
Maeder M, Conen D, Schaub N, Potocki M, Breidthardt T, Noveanu M, Reichlin T, Surnier Y, Staub D, Mueller C. Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides. International journal of cardiology 2009
Nov 6, 2009Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides
Nov 6, 2009International journal of cardiology 2009
Maeder Micha, Conen David, Schaub Nora, Potocki Mihael, Breidthardt Tobias, Noveanu Markus, Reichlin Tobias, Surnier Yves, Staub Daniel, Mueller Christian
Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease
Maeder M, Brutsche M, Christ A, Reichlin T, Staub D, Noveanu M, Breidthardt T, Potocki M, Mueller C. Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease. Respiratory medicine 2009; 103:1337-45.
Sep 1, 2009Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease
Sep 1, 2009Respiratory medicine 2009; 103:1337-45
Maeder Micha, Brutsche Martin, Christ Andreas, Reichlin Tobias, Staub Daniel, Noveanu Markus, Breidthardt Tobias, Potocki Mihael, Mueller Christian
B-type natriuretic peptides for the evaluation of exercise intolerance
Mueller C, Maeder M, Christ A, Reichlin T, Staub D, Noveanu M, Breidthardt T, Potocki M, Brutsche M. B-type natriuretic peptides for the evaluation of exercise intolerance. The American journal of medicine 2009; 122:265-72.
Mar 1, 2009B-type natriuretic peptides for the evaluation of exercise intolerance
Mar 1, 2009The American journal of medicine 2009; 122:265-72
Mueller Christian, Maeder Micha, Christ Andreas, Reichlin Tobias, Staub Daniel, Noveanu Markus, Breidthardt Tobias, Potocki Mihael, Brutsche Martin